Pathstone Holdings’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
3,474
-2,757
-44% -$198K ﹤0.01% 2127
2026
Q1
$444K Sell
6,231
-1,371
-18% -$93.8K ﹤0.01% 1798
2025
Q4
$450K Sell
7,602
-428
-5% -$23.2K ﹤0.01% 1789
2025
Q3
$443K Buy
8,030
+836
+12% +$43.5K ﹤0.01% 1824
2025
Q2
$310K Sell
7,194
-223
-3% -$8.6K ﹤0.01% 1915
2025
Q1
$294K Buy
7,417
+178
+2% +$7.88K ﹤0.01% 1943
2024
Q4
$295K Buy
7,239
+2,096
+41% +$87.3K ﹤0.01% 1977
2024
Q3
$201K Sell
5,143
-1,734
-25% -$69.1K ﹤0.01% 2175
2024
Q2
$301K Buy
6,877
+387
+6% +$18.7K ﹤0.01% 1939
2024
Q1
$310K Buy
6,490
+647
+11% +$29.1K ﹤0.01% 1934
2023
Q4
$276K Buy
+5,843
New +$243K ﹤0.01% 1882

Other funds holding NGVT

Pathstone Holdings's NGVT Position: Q2 2026 in Review

Pathstone Holdings reduced its Ingevity (NGVT) stake by 44% in Q2 2026, selling an estimated $198K and leaving 3,474 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Pathstone Holdings first reported a position in NGVT in Q4 2023 and has held it in 11 quarters since. The position peaked at $450K in Q4 2025. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Pathstone Holdings held 3,474 shares of Ingevity worth $259K as of Q2 2026.
  • Pathstone Holdings sold 2,757 Ingevity shares in Q2 2026, an estimated $198K.
  • Ingevity made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2127 holding.
  • Pathstone Holdings first reported a position in Ingevity in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Ingevity position peaked at $450K in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.